Without any signification PRs in the coming week, this next round of dilution will most likely push the SP lower. At this point it seems highly that Leronlimab will be approved for Combo, so the milestone payments and 50% share of profit are less than 12 months away. The cash burn between now and then will hopefully be covered by a milestone payment for submitting the BLA. The amount of funds raised in the coming week should give us an idea if there is a milestone payment for BLA submission and how much the milestone payment may be. In the meantime, the dilution May lead to a lower SP. How low? Who knows, but I’ve got more funds to decrease my 4+ year average on CYDY!